http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2018074533-A1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-33 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-74 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
filingDate | 2017-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2019-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-WO2018074533-A1 |
titleOfInvention | Immunoassay method using anti-human BNP fragment (4-32) antibody |
abstract | The present invention aims to provide information useful for the diagnosis and prediction of heart disease simply by detecting a specific human BNP fragment and measuring the human BNP fragment ratio only by immunoassay. It is an object of the present invention to provide a method capable of measuring an untreated human BNP fragment (4-32) with a specific antibody. A method for immunoassay of a human BNP fragment (4-32) in a sample, which reacts with a human BNP fragment (4-32), and human full-length BNP (1-32), human BNP fragment (3-32) And an immunoassay method using an antibody that does not react with the human BNP fragment (5-32). Further, the present invention provides a measurement method in which the antibody is an antibody that reacts with a site containing the N-terminus of human BNP fragment (4-32), or an antibody that reacts with human BNP fragment (4-10). |
priorityDate | 2016-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 69.